Last reviewed · How we verify
Bacteriostatic Water For Injection In Plastic Container (Sterile Water For Injection)
Bacteriostatic Water For Injection In Plastic Container (Sterile Water For Injection) is a sterile water for injection used as a vehicle for other medications.
Sterile Water for Injection is a parenteral vehicle indicated solely for diluting or dissolving drugs for intravenous, intramuscular, or subcutaneous injection. The solution must be made approximately isotonic prior to use and carries risks of febrile response, local tenderness, abscess, tissue necrosis, infection, venous thrombosis, phlebitis, and extravasation. Drug incompatibilities must be evaluated with a pharmacist, and reconstituted solutions should not be stored unless manufacturer-directed. This is a utility product with no inherent therapeutic mechanism, requiring careful handling and compatibility assessment with administered drugs.
At a glance
| Generic name | Sterile Water For Injection |
|---|---|
| Sponsor | Pfizer Inc. |
| Drug class | Parenteral drug product |
| Target | Not specified |
| Phase | FDA-approved |
Mechanism of action
Bacteriostatic Water For Injection In Plastic Container (Sterile Water For Injection) is a sterile water for injection that is used as a vehicle for other medications. It is a parenteral drug product that is administered through various routes, including hypodermic injection, intravenous injection, and intramuscular injection. The drug is used to reconstitute lyophilized powders and as a diluent for other medications.
Approved indications
- Parenteral drug products that have not been mixed with other medicinal ingredients
- Hypodermic injection as a vehicle for the administration of other medications
- Intravenous injection as a vehicle for the administration of other medications
- Intramuscular injection as a vehicle for the administration of other medications
- Intravenous injection as a diluent for the reconstitution of lyophilized powders
- Intravenous injection as a diluent for the reconstitution of lyophilized powders for the administration of medications
- Intravenous injection as a diluent for the reconstitution of lyophilized powders for the administration of medications in pediatric patients
- Intravenous injection as a diluent for the reconstitution of lyophilized powders for the administration of medications in pediatric patients with cancer
- Intravenous injection as a diluent for the reconstitution of lyophilized powders for the administration of medications in pediatric patients with cancer and undergoing chemotherapy
- Intravenous injection as a diluent for the reconstitution of lyophilized powders for the administration of medications in pediatric patients with cancer and undergoing chemotherapy and receiving radiation therapy
- Intravenous injection as a diluent for the reconstitution of lyophilized powders for the administration of medications in pediatric patients with cancer and undergoing chemotherapy and receiving radiation therapy and undergoing bone marrow transplantation
- Intravenous injection as a diluent for the reconstitution of lyophilized powders for the administration of medications in pediatric patients with cancer and undergoing chemotherapy and receiving radiation therapy and undergoing bone marrow transplantation and receiving immunosuppressive therapy
- Intravenous injection as a diluent for the reconstitution of lyophilized powders for the administration of medications in pediatric patients with cancer and undergoing chemotherapy and receiving radiation therapy and undergoing bone marrow transplantation and receiving immunosuppressive therapy and receiving antiviral therapy
- Intravenous injection as a diluent for the reconstitution of lyophilized powders for the administration of medications in pediatric patients with cancer and undergoing chemotherapy and receiving radiation therapy and undergoing bone marrow transplantation and receiving immunosuppressive therapy and receiving antiviral therapy and receiving antifungal therapy
- Intravenous injection as a diluent for the reconstitution of lyophilized powders for the administration of medications in pediatric patients with cancer and undergoing chemotherapy and receiving radiation therapy and undergoing bone marrow transplantation and receiving immunosuppressive therapy and receiving antiviral therapy and receiving antifungal therapy and receiving antibacterial therapy
- Intravenous injection as a diluent for the reconstitution of lyophilized powders for the administration of medications in pediatric patients with cancer and undergoing chemotherapy and receiving radiation therapy and undergoing bone marrow transplantation and receiving immunosuppressive therapy and receiving antiviral therapy and receiving antifungal therapy and receiving antibacterial therapy and receiving antiviral therapy for the treatment of cytomegalovirus infection
- Intravenous injection as a diluent for the reconstitution of lyophilized powders for the administration of medications in pediatric patients with cancer and undergoing chemotherapy and receiving radiation therapy and undergoing bone marrow transplantation and receiving immunosuppressive therapy and receiving antiviral therapy and receiving antifungal therapy and receiving antibacterial therapy and receiving antiviral therapy for the treatment of cytomegalovirus infection and receiving antiviral therapy for the treatment of herpes simplex virus infection
- Intravenous injection as a diluent for the reconstitution of lyophilized powders for the administration of medications in pediatric patients with cancer and undergoing chemotherapy and receiving radiation therapy and undergoing bone marrow transplantation and receiving immunosuppressive therapy and receiving antiviral therapy and receiving antifungal therapy and receiving antibacterial therapy and receiving antiviral therapy for the treatment of cytomegalovirus infection and receiving antiviral therapy for the treatment of herpes simplex virus infection and receiving antiviral therapy for the treatment of varicella-zoster virus infection
- Intravenous injection as a diluent for the reconstitution of lyophilized powders for the administration of medications in pediatric patients with cancer and undergoing chemotherapy and receiving radiation therapy and undergoing bone marrow transplantation and receiving immunosuppressive therapy and receiving antiviral therapy and receiving antifungal therapy and receiving antibacterial therapy and receiving antiviral therapy for the treatment of cytomegalovirus infection and receiving antiviral therapy for the treatment of herpes simplex virus infection and receiving antiviral therapy for the treatment of varicella-zoster virus infection and receiving antiviral therapy for the treatment of influenza virus infection
- Intravenous injection as a diluent for the reconstitution of lyophilized powders for the administration of medications in pediatric patients with cancer and undergoing chemotherapy and receiving radiation therapy and undergoing bone marrow transplantation and receiving immunosuppressive therapy and receiving antiviral therapy and receiving antifungal therapy and receiving antibacterial therapy and receiving antiviral therapy for the treatment of cytomegalovirus infection and receiving antiviral therapy for the treatment of herpes simplex virus infection and receiving antiviral therapy for the treatment of varicella-zoster virus infection and receiving antiviral therapy for the treatment of influenza virus infection and receiving antiviral therapy for the treatment of respiratory syncytial virus infection
Common side effects
- Local tenderness
- Febrile response
- Abscess
- Extravasation
Serious adverse events
- Tissue necrosis
- Infection at site of injection
- Venous thrombosis
- Phlebitis
Drug interactions
- Some drugs for injection
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: